Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents
Yingqi Luo, Wenhao Wu, Dailong Zha, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 47, pp. 128230-128230
Closed Access | Times Cited: 25

Showing 25 citing articles:

Pharmacological activity and mechanism of pyrazines
Wen Hou, Wei Dai, Hao Huang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115544-115544
Closed Access | Times Cited: 31
Synthesis, cytotoxicity, anti-inflammatory, anti-metastatic and anti-oxidant activities of novel chalcones incorporating 2-phenoxy-N-arylacetamide and thiophene moieties: induction of apoptosis in MCF7 and HEP2 cells
Nada S. Ibrahim, Hager Ahmed Sayed, Marwa Sharaky, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 10091-10107
Open Access | Times Cited: 5
A review of the current status of biological effects of plant-derived therapeutics in breast cancer
Shantanu Pachal, Hitesh Kumar, Rupshee Jain, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Bridging the gap between theory and treatment: Transition metal complexes as successful candidates in medicine
Sara Abdolmaleki, Alireza Aliabadi, Samad Khaksar
Coordination Chemistry Reviews (2025) Vol. 531, pp. 216477-216477
Closed Access
Ligustrazine as a multitarget scaffold in drug design and discovery
Xueyang Jiang, Siyi Li, Ning Wang, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 121, pp. 118110-118110
Closed Access
Mechanistic insights into novel cyano-pyrimidine pendant chalcone derivatives as LSD1 inhibitors by docking, ADMET, MM/GBSA, and molecular dynamics simulation
Amisha Gupta, Darakhshan Parveen, Faizul Azam, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101937-101937
Open Access
[1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice
Amr Ahmed WalyEldeen, Haidan M. El-Shorbagy, Hamdi M. Hassaneen, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 10, pp. 1225-1238
Open Access | Times Cited: 18
Natural Products–Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry
Guoqing Chen, Hongyan Guo, Zhe‐Shan Quan, et al.
Molecules (2023) Vol. 28, Iss. 21, pp. 7440-7440
Open Access | Times Cited: 10
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
Curcumin-Piperlongumine Hybrid Molecule Increases Cell Cycle Arrest and Apoptosis in Lung Cancer through JNK/c-Jun Signaling Pathway
Qianwen Zhang, Min Hui, Guo Chen, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 13, pp. 7244-7255
Closed Access | Times Cited: 3
Design, synthesis, and biological evaluation of chalcone acetamide derivatives against triple negative breast cancer
Puneet Kumar, Ruhi Singh, Deepak Sharma, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 107, pp. 129795-129795
Closed Access | Times Cited: 2
Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors
Diaaeldin M. Elimam, Wagdy M. Eldehna, Rofaida Salem, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114008-114008
Closed Access | Times Cited: 17
Advances in chalcone derivatives: Unravelling their anticancer potential through structure-activity studies
Khursheed Ahmad Sheikh, Amisha Gupta, Mohammad Faisal Umar, et al.
Journal of Molecular Structure (2023) Vol. 1299, pp. 137154-137154
Closed Access | Times Cited: 6
Ferulic acid, ligustrazine, and tetrahydropalmatine display the anti-proliferative effect in endometriosis through regulating Notch pathway
Xueshan Dai, Qinghua Wei, Xin Guo, et al.
Life Sciences (2023) Vol. 328, pp. 121921-121921
Closed Access | Times Cited: 5
Pyrazine Moiety: Recent Developments in Cancer Treatment
Rakesh Sahu, Kamal Shah, Yash Gautam, et al.
Current Organic Chemistry (2023) Vol. 27, Iss. 10, pp. 821-843
Closed Access | Times Cited: 5
New Oxazolo[5,4-d]pyrimidines as Potential Anticancer Agents: Their Design, Synthesis, and In Vitro Biological Activity Research
Aleksandra Sochacka-Ćwikła, Marcin Mą̨czyński, Żaneta Czyżnikowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11694-11694
Open Access | Times Cited: 8
Exploring the Therapeutic Potential of Chalcones in Oncology: A Comprehensive Review
Chandra Shekhar Yadav, Iqbal Azad, Abdul Rahman Khan, et al.
Current Bioactive Compounds (2023) Vol. 20, Iss. 6
Closed Access | Times Cited: 4
A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK
Yan Ma, Qian Cui, Wenjing Zhu, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1531-1546
Open Access
Physiochemical properties optimization of synthetic bio-destructible 2,6-bisarylidene-4-(t.-butyl)cyclohexanones to select a potential anti-cancer drug contender
Janarthanan Sekar, Meenambigai Ganesan, K. Manivel, et al.
Journal of Molecular Structure (2024), pp. 140836-140836
Closed Access
Synthesis and in vitro anticancer evaluation of novel flavonoid-based amide derivatives as regulators of the PI3K/AKT signal pathway for TNBC treatment
Dailong Zha, Yuanzhi Li, Yingqi Luo, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 9, pp. 1082-1099
Open Access | Times Cited: 3
Synthesis and Discovery of Ligustrazine–Heterocycle Derivatives as Antitumor Agents
Shi‐Tang Ma, Ning Zhang, Jiafu Hou, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 3
Synthesis and in-vitro study of a novel ligustrazine diselenide as a potential chemotherapy drug for lung adenocarcinoma
Mudan Guo, En Zhang, Guiling Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 114699-114699
Open Access | Times Cited: 1
Effects of Chalcone Derived Compounds on Cell Cycle and Migration Capability of Human Breast and Lung Cancer Cells
Hakan Avci, H Gunduz Altintas, Yaren YILDIZ, et al.
Biology Bulletin (2023) Vol. 50, Iss. 5, pp. 749-760
Closed Access | Times Cited: 1
An Updated Review on Recent Advancements in the Diverse Biological Applications of Medicinally Privileged Scaffold: Chalcone and its derivatives
Praveen Sekar, Shridharshini Kumar, Raju Senthil Kumar
International Journal of Medical Sciences and Pharma Research (2023) Vol. 9, Iss. 1, pp. 7-20
Open Access
Kalkon Türevlerinin Antikanser Mekanizmaları
Yaren YILDIZ, Ferda Arı
Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi (2023) Vol. 13, Iss. 3, pp. 1633-1646
Open Access
Page 1

Scroll to top